Skip to Content
Søg Menu

Overall survival in patients with advanced stage Hodgkin’s Lymphoma improves on Brentuximab Vedotin

Brentuximab Vedotin plus chemotherapy as first-line treatment improves the overall survival in patients suffering from stage III or IV Hodgkin’s Lymphoma. Get an update on the ECHELON-1 trial by investigator Stephen Ansell in this MEDtalk.
Stephen Ansell

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Tarec Christoffer El-galaly

Opsigtvækkende fremskridt på EHA for behandling af lymfom

/ Tarec Christoffer El-Galaly
EHA24Lymfom Play the Video 08:27
Jelena Jelicic

More Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Can Participate in Clinical Studies

/ Jelena Jelicic
EHA24Lymfom Play the Video 03:34
Ari Melnick

Presidential Symposium: Unmet Needs in the Lymphoma Field

/ Ari M. Melnick
EHA24Lymfom Play the Video 5:11
Ingrid Glimelius

Elderly Patients with Mantle Cell Lymphoma Need to be More Intensively Treated

/ Ingrid Glimelius
EHA24Lymfom Play the Video 1:50
Michael Wang

LBA: Acalabrutinib plus Bendamustine and Rituximab Show Significant Improvement in PFS for Elderly Patients with Mantle Cell Lymphoma

/ Michael Wang
EHA24Lymfom Play the Video 04:08
Patrick Nylund

The Blood Proteome Predicts High Risk of Relapse in Mantle Cell Lymphoma Patients

/ Patrick Nylund
EHA24Lymfom Play the Video 01:57
Ryan Jacobs

EHA24: Updated Results on the AZD-0486 Trial for Treating Relapsed Refractory Follicular Lymphoma

/ Ryan Jacobs
EHA24Lymfom Play the Video 4:48
Cathy Burton

Paradigm Changes in Hodgkin’s Lymphoma Treatments

/ Cathy Burton
ASCO24Hodgkins lymfomLymfom Play the Video 19:00

The Potential of Nanopore Sequencing to Profile Lymphoproliferative Malignancies and Other Neoplasms

/ Marcus Høy Hansen
LymfomMyelomatose
Back to top